Portrai Insights

Insights on data analysis, AI, and the platform we're building at Portrai.

Showing articles by Daeseung Lee

Latest

1 articles

Target-based Understanding the Termination of the AMG 794 Clinical Trial: A Deep Dive with spatial transcriptomics data

Amgen has exited the competitive development of Claudin 6 (CLDN6) therapies, which is still in its early stages, based on initial data from preclinical studies. Amgen, on July 5th 2024, had terminated

Daeseung Lee-Jun 27, 2024

WRITTEN BY

Portrai's Authors

Capturing and compounding Portrai's insights.

Daeseung Lee

CEO

Physician-scientist who left clinical practice to bring spatial biology into oncology drug discovery

1 articles

Hongyoon Choi

CTO

Builds the algorithms that turn spatial transcriptomics into actionable target intelligence

3 articles

Hyung-Jun Im

CSO

Nuclear medicine specialist linking imaging biomarkers to next-generation radiopharmaceuticals

0 articles

Kwonjoong Na

CMO

Translates platform insights into IND-enabling decisions across oncology programs

0 articles

Portrai

Official posts from the Portrai team, decoding disease with spatial intelligence

55 articles